Infertility
Conditions
Interventions
Placebo Group :taking placebo
Sponsors
The Women and Children's Hospital of Guangdong Province
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: (1) Patients aged 20 to 40 years; (2) Sum of AFC in both ovaries 2.0; AMH<1.1 ng/ml (Two out of three are sufficient); (3) Patients preparing to assist pregnancy by IVF-ET{ Antagonist regimen and high progesterone induced ovulation (PPOS) regimen}; (4) legal couple; (5) Patients who volunteered to participate in the trial and had signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Severe (III, IV) endometriosis; (2) Adenomyosis; (3) Untreated endometrial disease; (4) Diminished ovarian reserve due to bilateral or unilateral ovariectomy; (5) Having a medical condition that is not suitable for current assisted reproductive technology or for pregnancy; (6) Hydrosalpinx; (7) Embryo transfer failure for 3 times or more; (8) DOR patients who received other Chinese patent medicine for kidney-tonifying within 1 month (30 days) before enrollment; (9) Patients with previous ovarian resistance syndrome.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| High quality embryo number rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| number of oocyte retrieved;available number of embryos rate;rate of oocyte retrieval cancellation;rate of failed oocyte retrieval;non-available embryo rate;2PN cleavage number;implantation rate;clinical pregnancy rate;live birth rate; | — |
Countries
China
Contacts
Public ContactFenghua Liu
The Women and Children's Hospital of Guangdong Province
Outcome results
None listed